Effect of EPHA1 Genetic Variation on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keywords

Neuroimaging, Cerebrospinal fluid, Disease, Cognitive impairment, Cognition

References

• In vivo neuroanatomy of Alzheimer's disease: evidence from structural and functional brain imaging.Philippe Poulin, Konstantine K. Zakzanis — 2002
• Multiple roles of eph receptors and ephrins in neural developmentDavid G. Wilkinson — 2001
• Synaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer DiseaseStephen W. Scheff, D. A. Price, Frederick A. Schmitt — 2011
• Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI StudyRobyn A. Honea, Eric D. Vidoni, Amith Harsha — 2009
• The three new pathways leading to Alzheimer's diseaseKevin Morgan — 2011
• Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer’s DiseaseTimo Grimmer, Susanne Tholen, Behrooz H. Yousefi — 2010
• Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer DiseaseDaniel A. Llano, Viswanath Devanarayan, Adam J. Simon — 2013
• Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDGJonghan Shin, Sang‐Yoon Lee, Seog Ju Kim — 2010
• Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune SystemChristopher Carter — 2011
• Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairmentXiaolan Hu, Eve H. Pickering, Sara Hall — 2011
• Bidirectional modulation of synaptic functions by Eph/ephrin signalingRüdiger Klein — 2009
• Transmembrane domain of EphA1 receptor forms dimers in membrane-like environment.Elena O. Artemenko, N. S. Egorova, Alexander S. Arseniev — 2008
• Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid PeptidesAngela J. Hanson, Jennifer L. Bayer-Carter, Pattie S. Green — 2013
• Neuropathological basis of age-associated brain atrophyDeniz Erten‐Lyons, Hiroko H. Dodge, Randall L. Woltjer — 2013
• Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.Annika Olsson, Hugo Vanderstichele, Niels Andreasen — 2005
• Hypometabolism in Alzheimer's-Affected Brain Regions in Cognitively Normal Latinos Carrying the Apolipoprotein E ε4 AlleleJessica B. Langbaum, Kewei Chen, Richard J. Caselli — 2010
• Alzheimer’s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plansAndrew J. Saykin, Li Shen, Tatiana Foroud — 2010
• The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseGuy M. McKhann, David S. Knopman, Howard Chertkow — 2011
• Non-familial Alzheimer's disease is mainly due to genetic factorsJ. Wesson Ashford, James A. Mortimer — 2002
• Relationship between atrophy and β‐amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L. Villemagne, Pierrick Bourgeat — 2010

Cited by

• New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studiesPresentació Mora Juan — 2018
• The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s diseaseSeoyoung Yoon, Yong‐Ku Kim — 2015
• Microglial malfunction: the third rail in development of Alzheimer’s diseaseSiddhita D. Mhatre, Connie Tsai, Amanda J. Rubin — 2015
• Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease CohortsAlzheimer’s Disease Neuroimaging Initiative, Xi‐Chen Zhu, Hui-Fu Wang — 2016
• The Role of Ephs and Ephrins in Memory FormationMonica Dines, Raphael Lamprecht — 2015
• Impact of SORL1 genetic variations on MRI markers in non-demented eldersRuihua Yin, Alzheimer’s Disease Neuroimaging Initiative, Jun Li — 2016
• Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohortsLin Tan, Hui-Fu Wang, Meng‐Shan Tan — 2016
• Genes associated with Alzheimer's disease: an overview and current statusMohan Giri, Lu Yang, Man Zhang — 2016
• The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolismEddie Stage, Tuğçe Duran, Shannon L. Risacher — 2016
• Recent publications from the Alzheimer’s Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsMichael W. Weiner, Dallas P. Veitch, Paul Aisen — 2017
• A Set-Based Mixed Effect Model for Gene-Environment Interaction and Its Application to Neuroimaging PhenotypesChangqing Wang, Jianping Sun, Bryan Guillaume — 2017
• Predicting Cognitive Decline: Genetic, Environmental and Lifestyle Risk FactorsShea J. Andrews — 2017
• Research progress on pathological changes of brain caused by status epilepticusLe Zhang, F. Bi, Yi Shu — 2015
• Genetics of Alzheimer's disease: From pathogenesis to clinical usage.Wen Shao, Dantao Peng, Xiaomin Wang — 2017
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic ReviewErwin Lemche — 2018
• Associations of the Top 20 Alzheimer Disease Risk Variants With Brain AmyloidosisLiana G. Apostolova, Shannon L. Risacher, Tuğçe Duran — 2018
• The genetic landscape of Alzheimer disease.Susana Carmona, John Hardy, Rita Guerreiro — 2018
• Protective Variants in Alzheimer’s DiseaseShea J. Andrews, Brian Fulton‐Howard, Alison Goate — 2019
• Genetic Markers of Alzheimer's Disease.Matea Nikolac Perković, Nela Pivac — 2020
• Alzheimers Disease: A Brief ReviewSamantha McGirr, Courtney Venegas, Arun Swaminathan — 2020

Related papers

• The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): Validation of Structural MR ImagingEnrica Cavedo, Alberto Redolfi, Francesco Angeloni — 2014
• P3-104: GENE-BRAIN STRUCTURE NETWORKING ANALYSIS IN ALZHEIMER'S DISEASE USING THE PIPELINE ENVIRONMENTSeokwoo Moon, Lu Zhao, William Matloff — 2019
• Brain structure and allelic association in Alzheimer’s diseaseSeok Woo Moon, Ivo D. Dinov, Lu Zhao — 2020
• Creation of the Argentina‐Alzheimer's Disease Neuroimaging InitiativeMaría Julieta Russo, Deborah Gustafson, Silvia Vázquez — 2014
• Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type.Toshihiro Yoshizawa, Hajime Iwamoto, Hidehiro Mizusawa — 1992
• Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease.Hitesh Shetty, Harold W. Holloway, Mark B. Schapiro — 1996
• A composite multivariate polygenic and neuroimaging score for prediction of conversion to Alzheimer's diseaseRoman Filipovych, Bilwaj Gaonkar, Christos Davatzikos — 2012
• The Alzheimer's Disease Neuroimaging Initiative: Consistent 4D Cortical Thickness Measurement for Longitudinal Neuroimaging StudyYang Li, Yaping Wang, Zhong Xue — 2010
• The Alzheimer's disease neuroimaging initiative.Susanne G. Mueller, Michael W. Weiner, Leon J. Thal — 2005